The authors went on to demonstrate increase Trib2 autoantibodies in recent onset narcolepsy cases, a result that was replicated by our group and a Japanese study using sera samples from subjects collected in the 1990–2000s, and some cross-reactivity of sera with hypocretin neurons. The gene discussed is TRIB2; the disease is narcolepsy.